Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 9 studies | 33% ± 9% | |
macrophage | 7 studies | 20% ± 6% | |
endothelial cell | 5 studies | 19% ± 2% | |
plasmablast | 3 studies | 52% ± 20% | |
classical monocyte | 3 studies | 23% ± 2% | |
non-classical monocyte | 3 studies | 22% ± 6% | |
epithelial cell | 3 studies | 26% ± 8% | |
fibroblast | 3 studies | 20% ± 5% | |
dendritic cell | 3 studies | 27% ± 10% | |
plasmacytoid dendritic cell | 3 studies | 20% ± 1% |
Insufficient scRNA-seq data for expression of EDEM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1106.19 | 1445 / 1445 | 100% | 53.63 | 183 / 183 |
liver | 100% | 1815.99 | 226 / 226 | 100% | 70.78 | 406 / 406 |
lung | 100% | 2164.88 | 578 / 578 | 100% | 90.31 | 1155 / 1155 |
ovary | 100% | 924.30 | 180 / 180 | 100% | 84.13 | 430 / 430 |
pancreas | 100% | 1627.84 | 328 / 328 | 100% | 70.87 | 178 / 178 |
prostate | 100% | 1533.23 | 245 / 245 | 100% | 70.13 | 502 / 502 |
skin | 100% | 1432.41 | 1809 / 1809 | 100% | 89.98 | 472 / 472 |
stomach | 100% | 1059.62 | 359 / 359 | 100% | 79.29 | 286 / 286 |
kidney | 100% | 1547.45 | 89 / 89 | 100% | 71.53 | 900 / 901 |
breast | 100% | 1718.39 | 459 / 459 | 100% | 69.83 | 1116 / 1118 |
uterus | 100% | 1153.31 | 170 / 170 | 100% | 69.62 | 458 / 459 |
thymus | 100% | 1531.66 | 653 / 653 | 100% | 58.54 | 603 / 605 |
intestine | 100% | 1334.12 | 966 / 966 | 100% | 80.27 | 525 / 527 |
bladder | 100% | 1346.62 | 21 / 21 | 99% | 82.87 | 501 / 504 |
adrenal gland | 100% | 2324.38 | 258 / 258 | 99% | 46.32 | 227 / 230 |
brain | 95% | 713.01 | 2514 / 2642 | 100% | 46.29 | 704 / 705 |
adipose | 100% | 1832.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 77.17 | 29 / 29 |
spleen | 100% | 2942.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 69.34 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 55.63 | 1 / 1 |
blood vessel | 100% | 1298.87 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2546.72 | 923 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 35.98 | 79 / 80 |
heart | 98% | 894.11 | 842 / 861 | 0% | 0 | 0 / 0 |
muscle | 74% | 365.16 | 593 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904154 | Biological process | positive regulation of retrograde protein transport, ER to cytosol |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_1904382 | Biological process | mannose trimming involved in glycoprotein ERAD pathway |
GO_0006986 | Biological process | response to unfolded protein |
GO_0006058 | Biological process | mannoprotein catabolic process |
GO_1904380 | Biological process | endoplasmic reticulum mannose trimming |
GO_0036503 | Biological process | ERAD pathway |
GO_0019082 | Biological process | viral protein processing |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0044322 | Cellular component | endoplasmic reticulum quality control compartment |
GO_0004571 | Molecular function | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | EDEM2 |
Protein name | ER degradation-enhancing alpha-mannosidase-like protein 2 |
Synonyms | C20orf31 C20orf49 UNQ573/PRO1135 |
Description | FUNCTION: Involved in the endoplasmic reticulum-associated degradation (ERAD) pathway that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner . May initiate ERAD by promoting the first mannose trimming step of ERAD substrates, from Man9GlcNAc2 to Man8GlcNAc2 . Seems to recognize and bind to exposed hydrophobic regions in target proteins (By similarity). . |
Accessions | ENST00000374491.3 [Q9BV94-2] Q9BV94 ENST00000374492.8 [Q9BV94-1] |